Jillian B. Thomsen
2018
In 2018, Jillian B. Thomsen earned a total compensation of $6.2M as Senior Vice President Finance and Chief Accounting Officer at Nektar Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $424,100 |
---|---|
Option Awards | $899,490 |
Salary | $435,000 |
Stock Awards | $4,461,657 |
Other | $13,347 |
Total | $6,233,595 |
Thomsen received $4.5M in stock awards, accounting for 72% of the total pay in 2018.
Thomsen also received $424.1K in non-equity incentive plan, $899.5K in option awards, $435K in salary and $13.3K in other compensation.
Rankings
In 2018, Jillian B. Thomsen's compensation ranked 1,485th out of 14,244 executives tracked by ExecPay. In other words, Thomsen earned more than 89.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,485 out of 14,244 | 90th |
Division Manufacturing | 518 out of 5,765 | 91st |
Major group Chemicals And Allied Products | 165 out of 2,128 | 92nd |
Industry group Drugs | 130 out of 1,817 | 93rd |
Industry Pharmaceutical Preparations | 96 out of 1,391 | 93rd |
Source: SEC filing on April 30, 2019.
Thomsen's colleagues
We found four more compensation records of executives who worked with Jillian B. Thomsen at Nektar Therapeutics in 2018.
2018
Howard Robin
Nektar Therapeutics
Chief Executive Officer
2018
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
2018
Stephen Doberstein
Nektar Therapeutics
Chief Research and Development Officer
2018
Maninder Hora
Nektar Therapeutics